NHS expands access to prostate cancer drug in England to save thousands of lives

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year

The NHS has expanded access to a prostate cancer drug across England in a move expected to save thousands of lives.

Abiraterone, which starves cancer cells of the hormones they need to grow, will be offered to men who are newly diagnosed and whose disease has not spread beyond the prostate.